10 drug(s) with this reaction
3,537 total reports
Condition Aggravated has been reported as an adverse reaction across 10 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 3,537 adverse event reports mention condition aggravated in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with condition aggravated, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have condition aggravated listed in their FDA adverse event reports, sorted by report count:
In addition to condition aggravated, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
10 drug(s) manufactured by Chattem Inc have condition aggravated listed in their FDA adverse event reports: TRIAMCINOLONE ACETONIDE, LIDOCAINE, MENTHOL, FEXOFENADINE HYDROCHLORIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, MENTHOL, and others.
There are a combined 3,537 reports of condition aggravated across 10 Chattem Inc drug(s) in the FDA adverse event database.